Nanjing Well Pharmaceutical Group Co (SHSE:603351) ROCE % : 8.49% (As of Sep. 2024)

View and export this data going back to 2019. Start your Free Trial

What is Nanjing Well Pharmaceutical Group Co ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Nanjing Well Pharmaceutical Group Co's annualized ROCE % for the quarter that ended in Sep. 2024 was 8.49%.

Nanjing Well Pharmaceutical Group Co ROCE % Historical Data

The historical data trend for Nanjing Well Pharmaceutical Group Co's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nanjing Well Pharmaceutical Group Co ROCE % Chart

Nanjing Well Pharmaceutical Group Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

ROCE %

Get a 7-Day Free Trial

16.86

9.53

9.16

8.33

8.34

Nanjing Well Pharmaceutical Group Co Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
ROCE %	Get a 7-Day Free Trial															7.49	9.85	10.13	13.38	8.49

Nanjing Well Pharmaceutical Group Co ROCE % Calculation

Nanjing Well Pharmaceutical Group Co's annualized ROCE % for the fiscal year that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	136.692	/	( ( (2138.16 - 580.021)	+	(2278.903 - 557.748) )	/ 2 )
	=	136.692	/	( (1558.139	+	1721.155)	/ 2 )
	=	136.692	/	1639.647
	=	8.34 %

Nanjing Well Pharmaceutical Group Co's ROCE % of for the quarter that ended in Sep. 2024 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Sep. 2024 )		(Q: Jun. 2024 )		(Q: Sep. 2024 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Sep. 2024 )		(Q: Jun. 2024 )		(Q: Sep. 2024 )
	=	148.132	/	( ( (2345.378 - 618.015)	+	(2279.437 - 516.054) )	/ 2 )
	=	148.132	/	( ( 1727.363	+	1763.383 )	/ 2 )
	=	148.132	/	1745.373
	=	8.49 %

(1) Note: The EBIT data used here is four times the quarterly (Sep. 2024) EBIT data.

Nanjing Well Pharmaceutical Group Co (SHSE:603351) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Nanjing Well Pharmaceutical Group Co ROCE % Related Terms

Thank you for viewing the detailed overview of Nanjing Well Pharmaceutical Group Co's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Nanjing Well Pharmaceutical Group Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Nanjing Well Pharmaceutical Group Co Ltd (SHSE:603351) » Definitions » ROCE %

Traded in Other Exchanges

N/A

Address

No. 99, Changfeng Hexi Road, Nanjing Chemical Industry Park, Jiangsu Province, Nanjing, CHN, 210000

Website

http://www.well-js.com

Nanjing Well Pharmaceutical Group Co Ltd is engaged in research and development, production and sales of pharmaceutical auxiliary materials and synthetic lubricating base oil and other products. The company uses a variety of pharmaceutical dosage forms such as injection, oral administration and external use to guarantee the molding, effectiveness, stability and safety of pharmaceutical dosage forms.

Executives

Zou Jian Guo	senior management
Wang Fu Qiu	Directors, senior managers
Wu Rong Wen	Supervisors

Nanjing Well Pharmaceutical Group Co Headlines

No Headlines